Title: “Improving the Care of Patients with Advanced Renal Cell Carcinoma: Tapping into the Power of Collaborative Peer-focused Education”
Presented by: Johns Hopkins School of Medicine
Release Date: June 30, 2022
Expiration Date: June 30, 2023
Estimated time to complete this activity: 3 hours and 45 minutes. This activity has been approved for a maximum of 3.75 AMA PRA Category 1 Credits™.
Fees and Prerequisites: There are no fees or prerequisites.
Acknowledgement of Commercial Support: Supported by independent educational grants from Eisai Inc, Exelixis, Inc. and Merck Sharp & Dohme Corp.
This activity is intended to meet the educational needs of healthcare professionals involved in the care of patients with renal cell carcinoma.
After participating in this activity, learners will demonstrate the ability to:
Presented by the Johns Hopkins School of Medicine
The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
The Johns Hopkins University School of Medicine designates this enduring material for a maximum of 3.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other CreditsAmerican Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 CreditTM from organizations accredited by the ACCME.American Association of Nurse Practitioners National Certification Program accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
American Academy of PAs (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. PAs may receive a maximum of 3.75 AAPA Category 1 Credit for completing this program.
Statement of Need
Renal cell carcinoma (RCC) remains the most common variety of renal cancer, representing 90% of the diagnoses. Within the United States (US), it is a relatively common malignant caner, ranking as sixth and tenth most common for men and women respectively. Yet, the incidence has been slowly but steadily rising over the past thirty years. While localized RCC has a high survival rate, metastatic RCC only has a 5-20% 5-year survival rate. Previous forms of therapy at this stage had variable efficacy and poor tolerability in these advanced stages. The development of several agents has improved RCC outcomes and have improved tolerability: vascular endothelial growth factor inhibitors (VEGFi), mammalian target of rapamycin inhibitors, and immunotherapies. Of note, two main combinations of are approved in patients with RCC: (1) tyrosine kinase inhibitors (TKIs) with immuno-oncology (I-O) therapies and (2) two I-O agents. Educational programs that focus on this new and emerging approach are needed to aid clinicians in understanding the proper and safe use of I-O combinations. This collaborative social learning platform establishes a network of providers who can support each other locally, as well as those from different communities, with the goal of learning and sharing best practices that will improve outcomes for patients with renal cell carcinoma.
Johns Hopkins Faculty:
Yasser Mohamed Ali Ged, M.B.B.S.
Assistant Professor of Oncology
Johns Hopkins Hospital
Policy on Speaker and Provider Disclosure
It is the policy of the Johns Hopkins University School of Medicine that the speaker and provider globally disclose conflicts of interest. The Johns Hopkins University School of Medicine OCME has established policies in place that will identify and resolve conflicts of interest prior to this educational activity. Detailed disclosure will be made prior to presentation of the education.
Johns Hopkins Statement of Responsibility
The Johns Hopkins School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity.
Internet CME Policy
The Office of Continuing Medical Education (OCME) at the Johns Hopkins School of Medicine is committed to protecting the privacy of its members and customers. Johns Hopkins School of Medicine OCME maintains its Internet site as an information resource and service for physicians, other health professionals and the public. OCME at the Johns Hopkins School of Medicine will keep your personal and credit information confidential when you participate in a CME Internet based program. Your information will never be given to anyone outside of the Johns Hopkins School of Medicine CME program. CME collects only the information necessary to provide you with the services that you request.
All rights reserved - The Johns Hopkins School of Medicine. No part of this program may be used or reproduced in any manner whatsoever without written permission except in the case of brief quotations embodied in articles or reviews.
Format and Method of Participation
Review this internet-based CME activity. To take the post-test, please click on the post-test button below the video window of the player which will take you to the Johns Hopkins School of Medicine’s website. If you already have registered for other programs at this website, simply enter the requested information when prompted. Otherwise, complete the registration form to begin the testing process. The information you enter here will be used to generate your CME certificate. Please complete all fields to ensure accurate registration. Complete the post-test and evaluation and attest to the amount of time spent in the activity. Upon receiving a score of 70% or above, print your CME certificate.
Full Disclosure Policy Affecting CME Activities
As a provider approved by the Accreditation Council for Continuing Medical Education (ACCME), Johns Hopkins School of Medicine Office of Continuing Medical Education (OCME) requires attested and signed global disclosure of the existence of all financial interests or relationships with commercial interest from any individual in a position to control the content of a CME activity sponsored by OCME. The following relationships have been reported for this activity:
Yasser Mohamed Ali Ged, M.B.B.S. – Advisor: Aveo, BMS, Exelixis
Note: Grants to investigators at The Johns Hopkins University are negotiated and administered by the institution which receives the grants, typically through the Office of Research Administration. Individual investigators who participate in the sponsored project(s) are not directly compensated by the sponsor, but may receive salary or other support from the institution to support their effort on the project(s).
There are no references to off-label/unapproved uses of products in this program.
The opinions and recommendations expressed by faculty and other experts, whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of the Johns Hopkins School of Medicine name implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combinations of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
Privacy Statement/Internet Policy
The Office of Continuing Medical Education (CME) at the Johns Hopkins University School of Medicine is committed to protecting the privacy of its members and customers. The Johns Hopkins School of Medicine CME maintains its Internet site as an information resource and service for physicians, other health professionals and the public. Continuing Medical Education at the Johns Hopkins School of Medicine will keep your personal and credit information confidential when you participate in a CME Internet-based program. Your information will never be given to anyone outside of the Johns Hopkins School of Medicine's CME program. Continuing Medical Education collects only the information necessary to provide you with the services that you request.
AMERICANS WITH DISABILITIES ACT
The Johns Hopkins School of Medicine fully complies with the legal requirements of the ADA and the rules and regulations thereof. Please notify us if you have any special needs.